The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.
AstraZeneca’s Imjudo (tremelimumab) – an anti-CTLA4 antibody – in combination with Imfinzi (durvalumab) – an anti-PD-L1 antibody – has been approved by the US Food and Drug Administration (FDA) for the
They also looked at DNA samples from children who had participated in clinical trials for the Oxford-AstraZeneca vaccine.
The NIHR BRCs have supported almost 60, 000 experimental medicine research studies over the past nine years including the development of the Oxford AstraZeneca COVID-19 vaccine, as well as promising
Tezspire demonstrated reduced annualised rate of asthma exacerbations. AstraZeneca’s (AZ) Tezspire (tezepelumab) has been granted marketing authorisation in Great Britain by the Medicines and Healthcare products Regulatory Agency (MHRA) for
The European Commission (EC) has approved Aexion’s – part of the AstraZeneca Rare Disease group – Ultomiris (ravulizumab) in Europe as an add-on to standard therapy for generalised myasthenia gravis (gMG).
[ Previous 5 results ] 7 8 9 10 11 12 13 14 15 16 [ Next 5 results ]
We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...